Abstract
From October 1983 to October 1986, 39 patients with chronic osteomyelitis (of at least two month's duration) were treated with either pefloxacin (n=15), ofloxacin (n=17), or ciprofloxacin (n=7). The length of treatment ranged from 3 to 6 months; follow-up examinations were performed up until July 1988. The infecting bacterial strains (19Staphylococcus aureus, 2Staphylococcus epidermidis, 10Escherichia coli, 8Pseudomonas aeruginosa) were all sensitive to the quinolone prescribed. Twenty-nine of the 38 evaluable patients had a satisfactory outcome at follow-up examinations 14 to 48 months after the end of treatment. Fourteen of the 21 patients with gram-positive bacterial infections responded satisfactorily, as did 15 of the 17 patients infected by gram-negative bacteria. Nine cases of failure were observed (2 for pefloxacin, 4 for ofloxacin, 3 for ciprofloxacin). The infecting bacteria wereStaphylococcus aureus in six cases (3 on ofloxacin, 3 on ciprofloxacin), andStaphylococcus epidermidis (ofloxacin),Escherichia coli (pefloxacin), andPseudomonas aeruginosa (pefloxacin) in one case each. In all these cases, local conditions (presence of a foreign body in 5 cases, sequestra in 3, and post-radiotherapy necrosis in 1) could have been responsible for treatment failure. Tolerance was good; adverse effects observed in the pefloxacin and ofloxacin groups disappeared after treatment was ended. Bone levels varied but were always superior to the MIC for the pathogen. In view of the satisfactory results, the possibility of oral administration, and the good tolerance, these quinolones should be considered as alternative agents for the treatment of chronic osteomyelitis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chapman, S. W. Osteomyelitis. In: Reese, R. E., Douglas, R. G. (ed.): A practical approach to infectious diseases. Little Brown, Boston, 1986.
Desplaces, N., Gutmann, L., Carlet, J., Guibert, J., Acar, J. F. The new quinolones and their combinations with other agents for therapy of severe infections. Journal of Antimicrobial Chemotherapy 1986, 17, Supplement A: 25–39.
Norden, C. W., Shinners, E. Ciprofloxacin as therapy for experimental osteomyelitis caused byPseudomonas aeruginosa. Journal of Infectious Diseases 1985, 151: 291–294.
Norden, C. W., Niederriter, K. Ofloxacin therapy for experimental osteomyelitis caused byPseudomonas aeruginosa. Journal of Infectious Diseases 1987, 155: 823–825.
Norden, C. W. Lessons learned from animal models of osteomyelitis. Reviews of Infectious Diseases 1988, 10: 103–110.
Gentry, L. O. Approach to the patient with chronic osteomyelitis. In: Remington, J. S., Swartz, M. N. (ed.): Current clinical topics in infectious diseases. Volume 8. McGraw Hill, New York, 1987.
Sirot, J., Lopitaux, R., Sirot, D., Rampon, S., Delisle, J. J., Dumont, C., Bussière, J. L., Cluzel, R. Etude comparative de la diffusion de la cephradine, de la tobramycine et de la rifampicine dans le fémur chez l'homme. Médécine et Maladies Infectieuses 1978, 4: 152–157.
Montay, G. G., Blain, Y., Roquest, F., Lehir, A. High performance liquid chromatography of pefloxacin and its main active metabolites in biological fluids. Journal of Chromatography 1983, 272: 359–365.
Garraffo, R., Dellamonica, P., Bernard, E., Etesse, H., Lapalus, P. Steady state serum pharmacokinetics and bioequivalence of 500 mg oral versus 200 mg intravenous ciprofloxacin. Clinical Pharmacology Research 1989, 1: 29–35.
Greenberg, R. N., Kennedy, D. J., Reilly, P. M., Luppen, K. L., Weinandt, W. J., Bollinger, M. R., Aguirre, F., Kodesch, F., Saeed, M. K. Treatment of bone, joint and soft tissue infections with oral ciprofloxacin. Antimicrobial Agents and Chemotherapy 1987, 31: 151–155.
Desplaces, N., Acar, J. F. New quinolones in the treatment of joint and bone infections. Reviews of Infectious Diseases 1988, 10: 179–183.
Bergan, T. Pharmacokinetics of fluorinated quinolones. In: Andriole, V. T. (ed.): The Quinolones. Academic Press, London, 1988.
Fong, I. W., Ledbetter, W. H., Vandenbroucke, A. C., Simbul, M., Rahm, V. Ciprofloxacin concentrations in bone and muscle after oral dosing. Antimicrobial Agents and Chemotherapy 1986, 29: 405–408.
Gristina, A. G., Costerton, J. W. Bacterial adherence to biomaterials and tissue. Journal of Bone and Joint Surgery 1985, 67 Supplement A: 264–273.
Marrie, T. J., Costerton, J. W. Mode of growth of bacterial pathogens in chronic polymicrobial human osteomyelitis. Journal of Clinical Microbiology 1985, 22: 924–933.
Dellamonica, P., Bernard, E., Etesse, H., Garraffo, R. The diffusion of pefloxacin into bone and the treatment of osteomyelitis. Journal of Antimicrobial Chemotherapy 1986, 17, Supplement B: 93–102.
Bernard, E., Etesse, H., Garraffo, R., Giaume, F., Dellamonica, P. Infections osseuses: traitement par l'ofloxacine à propos de 10 cas. Pathologie Biologie 1987, 35: 644–647.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dellamonica, P., Bernard, E., Etesse, H. et al. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis. Eur. J. Clin. Microbiol. Infect. Dis. 8, 1024–1030 (1989). https://doi.org/10.1007/BF01975163
Issue Date:
DOI: https://doi.org/10.1007/BF01975163